Načítá se...
Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point
BACKGROUND: The availability of large epidemiological or clinical data storing biological samples allow to study the prognostic value of novel biomarkers, but efficient designs are needed to select a subsample on which to measure them, for parsimony and economical reasons. Two-phase stratified sampl...
Uloženo v:
| Vydáno v: | BMC Med Res Methodol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8091513/ https://ncbi.nlm.nih.gov/pubmed/33941092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12874-021-01283-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|